source
- Former FDA leaders, pharma speak out on mifepristone“The fundamental question is: Who gets to regulate mifepristone?”STAT · 2mo ago↗ source
- FDA delays Leqembi decision; Artiva raises $300M; Pharvaris prices offering🗓️ FDA delays subcutaneous Leqembi decision: Originally slated for later this month, the decision date now falls on August 24, Biogen and Eisai said. The agency asked for more information from ...Endpoints · 2mo ago↗ source
- STAT+: Up and down the ladder: The latest comings and goingsFrom new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.STAT · 2mo ago↗ source